Importantly, these studies established the feasibility of using well-established, moderate-throughput acute and chronic seizure models [26, 57] to PSEN2 KO mice to define how AD-associated risk factors impact ASD efficacy and seizure susceptibility. This evidence concerns the gene PSEN2 and Alzheimer disease.